← 홈

ADC

1,032개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,032개
ADCBiologicBioNTech SEPhase 2

Paroxetine (Paroxetine)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#인기#항체약물접합체+2
임상시험 60상태 RECRUITING
ADCBiologicCastilla-La Mancha Health Servi…vedotin (RC48) combined wit…Phase 2

Perioperative treatment (Perioperative treatment)

Hepatoid Adenocarcinoma of Stomach · Hepatoid Adenocarcinoma of Stomach

#HepatoidAdenocarcinomaofStomach#ADC#Phase2#인기#항체약물접합체+3
임상시험 60상태 RECRUITING
ADCBiologicCzech Lymphoma Study GroupPhase 2

Prednisone tablet (Prednisone tablet)

Lymphoma, T-Cell, Peripheral · Lymphoma, T-Cell, Peripheral

#LymphomaT-CellPeripheral#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 85.5%임상시험 60상태 ACTIVE
ADCBiologicstaleQilu Pharmaceutical Co., Ltd.Phase 2

QL1706 (QL1706)

TNBC, Triple Negative Breast Cancer · Recurrent Cervical Cancer

#RecurrentCervicalCancer#ADC#Phase2#인기#항체약물접합체+5
임상시험 60상태 RECRUITING
ADCBiologicAscendis Pharma Endocrinology D…Preclinical

Targeted drugs (Targeted drugs)

Immune-related Adverse Event; Malignant Solid Tumors · Immune-related Adverse Event

#Immune-relatedAdverseEvent#ADC#Preclinical#인기#항체약물접합체+4
효능 ORR 15%임상시험 60상태 RECRUITING
ADCBiologicMylan Pharmaceuticals IncDM1A-mediated epigenetic si…Phase 1

Verapamil (Verapamil)

Recurrent Hodgkin Lymphoma; Refractory Hodgkin Lymphoma · FRα

#FR#ADC#Phase1#인기#항체약물접합체+5
임상시험 60상태 ACTIVE
ADCBiologicstaleCanadian Cancer Trials Groupderuxtecan (T-DXd) showed a…Phase 2

darolutamide (darolutamide)

Prostate Cancer · Genitourinary Cancers

#GenitourinaryCancers#ADC#Phase2#인기#항체약물접합체+4
임상시험 60상태 RECRUITING
ADCBiologicMerckVedotin ± Pe…Phase 2

nivolumab OR pembrolizumab (glembatumumab vedotin and PD-1 targeted checkpoint inhibitor, glembatumumab vedotin and PD-1 targeted checkpoint inhibitor (nivolumab OR pembrolizumab))

Melanoma · PD-1

#PD-1#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 50%임상시험 60상태 DISCONTINUED
ADCBiologicstaleGruppo Oncologico del Nord-OvestPhase 3

l-leucovorin (l-leucovorin)

Metastatic Colorectal Cancer · Gastric Cancer

#GastricCancer#ADC#Phase3#인기#항체약물접합체+3
효능 ORR 36.6%임상시험 60상태 ACTIVE
ADCBiologicPfizerPreclinical

pneumococcal conjugate vaccine (pneumococcal conjugate vaccine)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#ADC#Preclinical#인기#항체약물접합체+2
효능 ORR 89.87%임상시험 60상태 ACTIVE
ADCBiologicGlaxoSmithKlinePreclinical

pneumococcal polysaccharide vaccine (pneumococcal polysaccharide vaccine)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#ADC#Preclinical#인기#항체약물접합체+2
효능 ORR 89.87%임상시험 60상태 ACTIVE
ADCBiologicSeagen Inc.sPhase 1

rifampin (rifampin)

Carcinomas; Disease, Hodgkin · Carcinomas

#Carcinomas#ADC#Phase1#인기#항체약물접합체+5
임상시험 60상태 ACTIVE
ADCBiologicstaleMing-Yuan ChenPhase 3

Adjuvant Cisplatin (Adjuvant Cisplatin)

Locally Advanced Head and Neck Squamous Cell Carcinoma · Locally Advanced Head and Neck Squamous

#LocallyAdvancedHeadandNeckSquamo#ADC#Phase3#인기#항체약물접합체+2
효능 ORR 40%임상시험 59상태 RECRUITING
ADCBiologicstaleSWOG Cancer Research NetworksPhase 3

Afatinib Dimaleate (Afatinib Dimaleate)

Recurrent Non-Small Cell Lung Carcinoma; Stage IV Non-Small Cell Lung Cancer · FRα

#FR#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 96%임상시험 59상태 RECRUITING
ADCBiologicstaleFondazione per la Medicina Pers…releasePhase 2

Alpelisib (Alpelisib)

Breast Cancer; Gastrointestinal Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 43.3%임상시험 59상태 DISCONTINUED
ADCBiologicstaleGenentech, Inc.Preclinical

Anti-angiogenic drug (Anti-angiogenic drug)

Gastric Cancer; Second-line Treatment · Gastric Cancer

#GastricCancer#ADC#Preclinical#인기#항체약물접합체+3
효능 ORR 96%임상시험 59상태 RECRUITING
ADCBiologicstaleKaryopharm Therapeutics IncPhase 2

Clarithromycin (Clarithromycin)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#ADC#Phase2#인기#항체약물접합체+2
효능 ORR 6%임상시험 59상태 RECRUITING
ADCBiologicstaleMonika Joshi, MDviaPhase 3

Eribulin mesylate (Eribulin mesylate)

Metastatic Urothelial Cell Cancer · Breast Cancer

#BreastCancer#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 71.2%임상시험 59상태 RECRUITING
ADCBiologicstaleSWOG Cancer Research NetworkDM1) and/or trastuzumab der…Phase 3

HER2-targeted Therapy (HER2-targeted Therapy)

Anatomic Stage IV Breast Cancer AJCC v8; Metastatic HER2-Positive Breast Carcinoma · HER2

#HER2#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 18.75%임상시험 59상태 RECRUITING
ADCBiologicstaleMerck Sharp & Dohme LLCsPhase 2

Hyaluronidase (Hyaluronidase)

Diffuse Large B-cell Lymphoma · Diffuse Large B-cell Lymphoma

#DiffuseLargeB-cellLymphoma#ADC#Phase2#인기#항체약물접합체+3
효능 ORR 64.3%임상시험 59상태 DISCONTINUED

9 / 52 페이지

← 이전다음 →